Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-02-19 @ 12:15 AM
Study NCT ID:
NCT02292758
Status:
COMPLETED
Last Update Posted:
2022-01-31
First Post:
2014-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Sponsor:
Academic and Community Cancer Research United
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-13
First Submit QC Date:
None
Study First Post Date:
2014-11-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-31
Results First Submit QC Date:
None
Results First Post Date:
2020-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-27
Last Update Post Date:
2022-01-31
Last Update Post Date Type:
ACTUAL